AACR logo

More articles from Poster Presentations - Immunomodulatory Agents and Interventions

Abstract 6707: Inhibition of proteolytic cleavage of NKG2D ligands increases immune cell-mediated cell killing of tumor cells in vitro
Safak Yalcin, Vanessa Cicchini, Xin Du, Xin Wu, Tom Kaever, Neil Gibson

Cancer Research Aug 2020, 80 (16 Supplement) 6707; DOI: 10.1158/1538-7445.AM2020-6707
Abstract 6699: CUE-102 Immuno-STATs for selective targeting and expansion of WT1-specific T cells for the treatment of HLA-A02⁺and/or HLA-A24⁺patients with WT1⁺ malignancies
Dharma Thapa, Alex Histed, Jonathan Soriano, Luke Witt, Zohra Merazga, Natasha Girgis, Miguel Moreta, Fulvio Diaz, Fan Zhao, Melissa Kemp, Paige Ruthardt, Anish Suri, Steve Quayle, John Ross, Saso Cemerski

Cancer Research Aug 2020, 80 (16 Supplement) 6699; DOI: 10.1158/1538-7445.AM2020-6699
Abstract 6714: Genetic screens identify T cell co-stimulation as a key modifier of the redirected cytotoxicity of bispecific T cell engager (BiTE^®) molecules
Ye Shen, Patrick Collins, Jason Eng, Flordeliza Fajardo, Wendy Zhong, Olivier Nolan-Stevaux

Cancer Research Aug 2020, 80 (16 Supplement) 6714; DOI: 10.1158/1538-7445.AM2020-6714
Abstract 6712: Analysis of VEGF as a potential complimentary target with immunotherapy
Yulia Newton, Christopher W. Szeto, Stephen C. Benz, Sandeep K. Reddy

Cancer Research Aug 2020, 80 (16 Supplement) 6712; DOI: 10.1158/1538-7445.AM2020-6712
Abstract 6686: SO-C101 displays strong anti-tumor effect in TC-1 and TRAMP-C2 tumor mice and in combination with PD-1 blockade prevents tumor development in a NK and CD8⁺ T cells dependent manner
Irena Adkins, Romana Mikyskova, Nada Hradilova, Guy de Martynoff, David Bechard, Ulrich Moebius, Milan Reinis, Radek Spisek

Cancer Research Aug 2020, 80 (16 Supplement) 6686; DOI: 10.1158/1538-7445.AM2020-6686
Abstract 6685: A retrospective observational study of telomerase peptide immunotherapy in heavily treated solid cancer patients
Jonggwon Choi

Cancer Research Aug 2020, 80 (16 Supplement) 6685; DOI: 10.1158/1538-7445.AM2020-6685
Abstract 6693: Metronomic treatment of orally available oxaliplatin and pemetrexed to potentiate the efficacy of anti-PD-1 by modulating tumor immunity
Ruby Maharjan

Cancer Research Aug 2020, 80 (16 Supplement) 6693; DOI: 10.1158/1538-7445.AM2020-6693
Abstract 6697: DT095895, a selective EP₄ receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties
Anne-Laure Blayo, Laurène Deshons, Alexia Dumont, Christel Franchet, Célia Halter, Ludovic Herbin, Gaël Hommet, Stanislas Mayer, Alban Bessede, Imane Nafia, Marjorie Sidhoum, Xavier Leroy, Stephan Schann

Cancer Research Aug 2020, 80 (16 Supplement) 6697; DOI: 10.1158/1538-7445.AM2020-6697
Abstract 6695: Short linear peptide modulators of checkpoint receptor activity rescue suppression and enhance newly activated T cells
Vinayaka Kotraiah, Timothy Phares, Cecille Browne, Marc Mansour, James Pannucci, Gabe Gutierrez

Cancer Research Aug 2020, 80 (16 Supplement) 6695; DOI: 10.1158/1538-7445.AM2020-6695
Abstract 6713: Oncolytic adenoviruses expressing immune modulators enhance tumor cell killing in human cancer 3D microtumor models
Laura K. Springgay, Amy M. Strauwald, Brett Ewald, Joan M. Robbins, Winnie M. Chan

Cancer Research Aug 2020, 80 (16 Supplement) 6713; DOI: 10.1158/1538-7445.AM2020-6713

Main menu

User menu

Search

More articles from Poster Presentations - Immunomodulatory Agents and Interventions

Pages

Articles

Info for

About Cancer Research